Literature DB >> 12376400

Synergy between angiotensin and aldosterone in evoking sodium appetite in baboons.

R E Shade1, J R Blair-West, K D Carey, L J Madden, R S Weisinger, D A Denton.   

Abstract

The synergy between ANG II and aldosterone (Aldo) in the induction of salt appetite, extensively studied in rats, has been tested in baboons. ANG II was infused intracerebroventricularly at 0.5 or 1.0 microg/h; Aldo was infused subcutaneously at 20 microg/h. Separate infusions over 7 days had no significant effect on the daily intake of 300 mM NaCl. Concurrent infusions, however, increased daily NaCl intake approximately 10-fold and daily water intake approximately 2.5-fold. In addition, the combined infusions caused 1) a reduction in daily food intake, 2) changes in blood composition indicative of increased vasopressin release, and 3) changes of urinary excretion rates of cortisol and Aldo indicative of increased ACTH release. Arterial blood pressure, measured in two baboons, rose during concurrent ANG II and Aldo treatment. These results indicate a potent synergy between central ANG II and peripheral Aldo in stimulating salt appetite in baboons. At the same time, other ANG II-specific brain mechanisms concerned with water intake, food intake, vasopressin release, ACTH release, and blood pressure regulation appear to have been activated by the same type of synergy. These central enhancement processes have never been previously demonstrated in primates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376400     DOI: 10.1152/ajpregu.00248.2002

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

1.  Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure?

Authors:  Yang Yu; Shun-Guang Wei; Zhi-Hua Zhang; Elise Gomez-Sanchez; Robert M Weiss; Robert B Felder
Journal:  Hypertension       Date:  2008-01-28       Impact factor: 10.190

Review 2.  Understanding the Two Faces of Low-Salt Intake.

Authors:  Branko Braam; Xiaohua Huang; William A Cupples; Shereen M Hamza
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

3.  Central GIP signaling stimulates peripheral GIP release and promotes insulin and pancreatic polypeptide secretion in nonhuman primates.

Authors:  Paul B Higgins; Robert E Shade; Irám P Rodríguez-Sánchez; Magdalena Garcia-Forey; M Elizabeth Tejero; V Saroja Voruganti; Shelley A Cole; Anthony G Comuzzie; Franco Folli
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-16       Impact factor: 4.310

Review 4.  Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms.

Authors:  Yiling Fu; Volker Vallon
Journal:  Nephron Physiol       Date:  2014-11-06

5.  Differential effects of mineralocorticoid and angiotensin II on incentive and mesolimbic activity.

Authors:  Laura A Grafe; Loretta M Flanagan-Cato
Journal:  Horm Behav       Date:  2015-12-28       Impact factor: 3.587

6.  The role of the hypothalamic paraventricular nucleus and the organum vasculosum lateral terminalis in the control of sodium appetite in male rats.

Authors:  Laura A Grafe; Anne E Takacs; Daniel K Yee; Loretta M Flanagan-Cato
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

7.  β-Arrestin-Biased Agonist Targeting the Brain AT1R (Angiotensin II Type 1 Receptor) Increases Aversion to Saline and Lowers Blood Pressure in Deoxycorticosterone Acetate-Salt Hypertension.

Authors:  Mario Zanaty; Fernando A C Seara; Pablo Nakagawa; Guorui Deng; Natalia M Mathieu; Kirthikaa Balapattabi; Sadashiva S Karnik; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2020-11-30       Impact factor: 9.897

Review 8.  Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.

Authors:  Ewa Szczepanska-Sadowska; Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.